CSL Limited.
Australian biotechnology company
- Reports this week
- 0
- Active events
- 0
- Connections
- 48
What's happening
One to three months ago
-
Jefferies Financial Group downgraded the stock rating of CSL Limited on September 17, 2026.Some support3 reports
-
Global biotechnology company CSL, headquartered in Melbourne, focuses on specialty biotherapies and supplies raw materials for many therapies.Some support2 reports1 development inside
-
CSL Limited, based in Melbourne, announced a successful collaboration between emeritus researcher Frazer and Jian Zhou on HPV research, leading to licensed IP for cancer prevention in Australia.Some support3 reports
-
Analyst firms provided guidance and market commentary on August 1, 2026, involving RBC Capital Markets and CSL Limited.Some support1 report
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
Around CSL Limited this week
News at the entities that move CSL Limited most-
Novartis TransactionalNovartis developed a Bruton's tyrosine kinase inhibitor, with Heinz Wiendl being a professor at the University of Freiburg.Moves CSL Limited
-
Haemonetics StructuralThe FDA granted approval for a product manufactured by Haemonetics on October 28, 2026.Moves CSL Limited
-
Royal Bank of Canada Mentioned togetherRoyal Bank of Canada dropped its price objective for Crown Castle Inc., while Citigroup reiterated an outperform rating.Moves CSL Limited
-
Jefferies Financial Group Mentioned togetherDuolingo faced a downgrade and price target cut due to slowing user growth, according to an analyst report.Moves CSL Limited
-
Melbourne Shared contextVictoria Police is investigating a burglary that occurred at Basq, a dining precinct in Melbourne.Moves CSL Limited
-
MarketBeat Mentioned togetherMarketBeat released analyst recommendations for small-cap communication services companies Optimum Communications and Criteo.Moves CSL Limited
Connections
The 10 strongest of 48, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Novartis Transactional
Novartis divested its influenza vaccines business unit to CSL Limited, leading to the formation of Seqirus.
-
Haemonetics Structural
CSL Limited has established a supply agreement and plans to use Haemonetics' devices for plasma collection.
-
CSL Behring Structural
CSL Limited integrates CSL Behring as a core operational segment for its specialty biotherapies business.
-
CSL Plasma Structural
CSL Plasma supplies raw materials, functioning as a key component within the CSL Limited corporate structure.
-
Jefferies Financial Group Mentioned together
Jefferies Financial Group issued a rating downgrade for CSL Limited shares, later revising to hold.
-
Melbourne Shared context
CSL Limited is headquartered and operates within the city of Melbourne.
-
Royal Bank of Canada Mentioned together
Royal Bank of Canada provided a financial rating update on CSL Limited.
-
MarketBeat Mentioned together
MarketBeat provides consensus rating data regarding CSL Limited's market performance and status.
Show all 10 connections
-
RBC Capital Markets Mentioned together
RBC Capital Markets provides market guidance and commentary on CSL Limited.
-
Frazer Mentioned together
No direct evidence linking Frazer and CSL Limited was provided in the timeline.
History
Events by the month they beganSeptember 2026
1 eventAugust 2026
2 events- CSL Limited, based in Melbourne, announced a successful collaboration between emeritus researcher Frazer and Jian Zhou on HPV research, leading to licensed IP for cancer prevention in Australia.
- Analyst firms provided guidance and market commentary on August 1, 2026, involving RBC Capital Markets and CSL Limited.